- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on AMAG Pharmaceuticals Inc. (AMAG)
by latest | most commented
-
Closing Update for Wednesday, July 1
-
Wednesday's Options Recap
-
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
-
FDA Calendar Updates: AMAG Pharma, Takeda
-
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart
-
Expect FDA Approval of AMAG Pharmaceutical's Feraheme
-
FDA Calendar: 18 Hot Summer Trades
-
Galleon Bets Heavily on the S&P 500
-
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
-
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
-
AMAG Pharma: Strong Prospects for Feraheme's Success
-
3S Bio: Post-Earnings, Still a Buy
-
FDA, Clinical Trial Calendar Updates: AMAG Pharma, Immunomedics
-
FDA Calendar Updates: AMAG Pharma Up, Northfield Labs Down
-
Sequenom's Bombshell
-
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
-
Where Might Genentech Investors Redeploy $47B?
-
Three Oversold Healthcare Catalyst Stocks
-
Know Your Options When Investing in Biotech Stocks
-
Create Your Own Diagnostics ETF
-
Hedge Fund Portfolio Tracking: Galleon Group (Raj Rajaratnam), Q3 2008
-
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
-
20 Emerging Healthcare Stocks to Watch in '09
-
Trading FDA Decisions: AMAG Looks Like a Buy
-
Tuesday Options Update: EBAY, SBUX, GE & AMAG
-
Five Healthcare Stocks Positioned for a Happy New Year
-
FDA Calendar Update: High Hopes for Amgen's Bone Drug
-
AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA
-
Full FDA Calendar for Remainder 2008
-
Monday Options Update: AMAG, XME, THOR, MSFT, SLXP, CEG, ING, RIMM
-
Biotech Outlook: M&A Will Continue
-
AMAG's Iron Replacement Therapy: Great Potential, Problematic Trial
-
AMAG Pharma Should Jump on Jefferies Note
-
AMAG Pharma, 3SBio Partner to Develop Ferumoxytol Market in China
-
AMAG Pharma: What's Taking the FDA So Long?
-
Jeffries Out Bullish on Amag Pharma
-
AMAG Pharmaceuticals Worth Far Less - Merrill
-
Under The Radar News - Thursday
-
2007 Biotech Performance Review
-
Russell 3000's Best and Worst Performing Stocks - 5 Days, 3 Months, YTD
-
Best and Worst Performing Stocks Year to Date